Bruce A. Hironaka
Plus aucun poste en cours
Historique de carrière de Bruce A. Hironaka
Anciens postes connus de Bruce A. Hironaka
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Agenovir Corp.
 Agenovir Corp. Pharmaceuticals: MajorHealth Technology Agenovir Corp. provides research and developing novel antiviral therapeutics for diseases. The company was founded by Bruce Hironaka and Stephen R. Quake and is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | - | 08/12/2016 |
| Directeur Général | - | 08/12/2016 | |
| Fondateur | - | 08/12/2016 | |
IgGenix, Inc.
 IgGenix, Inc. BiotechnologyHealth Technology IgGenix, Inc. operates as a biotechnology company. It isolates and transforms allergen-specific IgE antibodies into IgG antibodies that are designed to alleviate and possibly prevent the allergic cascade. The company was founded by Stephen D. Quake, Kari Nadeau, Derek Croote, and Bruce Hironaka in 2019 and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | 01/01/2019 | - |
| Directeur Général | 01/01/2019 | - | |
| Fondateur | 01/01/2019 | - | |
Thios Pharmaceuticals, Inc.
 Thios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thios Pharmaceuticals, Inc. was engaged in providing researches therapies. The therapies provided by the company target sulfation pathways, which could lead to potential for treatments for inflammation, cancer and other diseases. Thios Pharmaceuticals was located in Oakland, CA. | President | 01/04/2002 | - |
Formation de Bruce A. Hironaka
| Stanford University | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Thios Pharmaceuticals, Inc.
Thios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thios Pharmaceuticals, Inc. was engaged in providing researches therapies. The therapies provided by the company target sulfation pathways, which could lead to potential for treatments for inflammation, cancer and other diseases. Thios Pharmaceuticals was located in Oakland, CA. | Health Technology |
Agenovir Corp.
Agenovir Corp. Pharmaceuticals: MajorHealth Technology Agenovir Corp. provides research and developing novel antiviral therapeutics for diseases. The company was founded by Bruce Hironaka and Stephen R. Quake and is headquartered in San Francisco, CA. | Health Technology |
IgGenix, Inc.
IgGenix, Inc. BiotechnologyHealth Technology IgGenix, Inc. operates as a biotechnology company. It isolates and transforms allergen-specific IgE antibodies into IgG antibodies that are designed to alleviate and possibly prevent the allergic cascade. The company was founded by Stephen D. Quake, Kari Nadeau, Derek Croote, and Bruce Hironaka in 2019 and is headquartered in South San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- Bruce A. Hironaka
- Expérience
